Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair Church

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neurobiology of Aging|December 15, 2010
A novel presenilin 1 mutation, I202F occurring at a previously predicted pathogenic site causing autosomal dominant Alzheimer's diseaseAlistair Church, Junita Prescott, Suzanne Lillis, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 25, 2019
A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar AtaxiaLliwen A Jones, Waqaar Baber, Mark Wardle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 9, 2010
Hyposmia in progressive supranuclear palsyLaura Silveira-Moriyama, Graham Hughes, Alistair Church, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.
Neurobiology of Aging|August 22, 2021
Altered network stability in progressive supranuclear palsyDavid J Whiteside, P Simon Jones, Boyd C P Ghosh, et al.
Brain : a Journal of Neurology|April 16, 2025
Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromesMichele T Hu, Agustin Querejeta Coma, James B Rowe, et al.
European Journal of Neurology|February 26, 2024
Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonismChristopher Kobylecki, Viorica Chelban, Yee Yen Goh, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Human Brain Mapping|June 3, 2023
Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndromeDavid J Whiteside, Duncan Street, Alexander G Murley, et al.
Brain Communications|September 11, 2025
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's diseaseWeihua Li, Nicholas P Lao-Kaim, Runtian Li, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neurobiology of Aging|December 15, 2010
A novel presenilin 1 mutation, I202F occurring at a previously predicted pathogenic site causing autosomal dominant Alzheimer's diseaseAlistair Church, Junita Prescott, Suzanne Lillis, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 25, 2019
A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar AtaxiaLliwen A Jones, Waqaar Baber, Mark Wardle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 9, 2010
Hyposmia in progressive supranuclear palsyLaura Silveira-Moriyama, Graham Hughes, Alistair Church, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.
Neurobiology of Aging|August 22, 2021
Altered network stability in progressive supranuclear palsyDavid J Whiteside, P Simon Jones, Boyd C P Ghosh, et al.
Brain : a Journal of Neurology|April 16, 2025
Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromesMichele T Hu, Agustin Querejeta Coma, James B Rowe, et al.
European Journal of Neurology|February 26, 2024
Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonismChristopher Kobylecki, Viorica Chelban, Yee Yen Goh, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Human Brain Mapping|June 3, 2023
Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndromeDavid J Whiteside, Duncan Street, Alexander G Murley, et al.
Brain Communications|September 11, 2025
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's diseaseWeihua Li, Nicholas P Lao-Kaim, Runtian Li, et al.
Pageof 2